Drug recall · August 22, 2018
Lisinopril Tablets USP recall
Why: Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lisinopril Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202, NDC 68180-980-03
- Lots / codes
Lot #: H800414, Exp. 12/2019
- Quantity
- 11,706 bottles
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- Product was distributed to distributors, mail order pharmacy and supermarkets throughout the United States.
- Initiated
- August 13, 2018 · Voluntary: Firm initiated
- Classified
- August 13, 2018
- Reported
- August 22, 2018
- Ended
- October 15, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lisinopril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.